List Results
Refine Search
Results by Topic
Results on Map
Search Details
Found 895 studies with search of: HCV
Hide studies that are not seeking new volunteers.
  Display Options
Rank Status Study
361 Recruiting Bavituximab Repeat-Dose Trial in Patients Co-Infected With Chronic Hepatitis C Virus and Human Immunodeficiency Virus
Conditions: Hepatitis C Virus;   HIV Infections
Intervention: Drug: bavituximab
362 Completed Treatment of Hepatitis C in Hemophilic Patients With HIV
Conditions: HIV Infections;   Hepatitis C;   Hemophilia
Interventions: Drug: Peginterferon alfa-2a;   Drug: Ribavirin
363 Not yet recruiting A Phase 1b/2a, Open-label,Randomized, Safety, Tolerability, Dose Finding, PK/PD, and Preliminary Efficacy Study of SC Hanferon™ in Combination With Ribavirin in Treatment-naïve Subjects With Genotype 1 Hepatitis C
Conditions: Chronic Hepatitis C Infection;   Genotype 1
Interventions: Drug: recombinant variant of interferon-alpha 2b;   Drug: Peginterferon alfa-2a
364 Recruiting Micro RNA-122 and the Clinical Course of Patients With Chronic Hepatitis C
Condition: Hepatitis C
Intervention:
365 Completed Efficacy and Safety of Escitalopram for Prevention of Depression Induced by Peg-Interferon in Hepatitis C Patients
Conditions: Major Depressive Disorder.;   Hepatitis C, Chronic
Interventions: Drug: Escitalopram;   Drug: Placebo
366 Completed CIFN and IFN γ-1b With or Without Ribavirin for Treatment of Chronic Hepatitis C (Nonresponders)
Condition: Chronic Hepatitis C
Intervention: Drug: Consensus Interferon-Alpha, Interferon Gamma-1b, Ribavirin
367 Completed Combination Drug Therapy for Patients With Hepatitis C
Conditions: Chronic Hepatitis C;   Fibrosis;   Hemolytic Anemia
Intervention: Drug: Ribavirin
368 Completed
Has Results 		Extended Treatment With PEG-Intron® and Rebetol® in Patients With Genotype 1 Chronic Hepatitis C and Slow Virologic Response (Study P03685AM3)(COMPLETED)
Condition: Hepatitis C, Chronic
Interventions: Drug: Combination of pegylated interferon alfa-2b (PEG-Intron®) and ribavirin (Rebetol®);   Drug: Combination of pegylated interferon alfa-2b and ribavirin
369 Recruiting Romiplostim in Treating Hepatitis C-Infected Patients With Thrombocytopenia
Conditions: Hepatitis C Infection;   Thrombocytopenia
Interventions: Biological: romiplostim;   Drug: ribavirin;   Other: placebo;   Biological: PEG-interferon alfa-2a;   Other: laboratory biomarker analysis
370 Active, not recruiting Fluvastatin Versus Hepatitis C Virus
Condition: Hepatitis C
Intervention: Drug: fluvastatin
371 Recruiting Evaluation of a Multi-Disciplinary Approach for the Treatment of Hepatitis C in IDUs (HI-LO Study)
Condition: Hepatitis C Virus Infection
Intervention: Drug: Interferon injections and ribavirin
372 Recruiting Characterization of Clonal B Cell Populations in HCV Infection
Condition: Hepatitis C
Intervention:
373 Recruiting Study of Maternal Hepatitis C Infection and Influenza Vaccination in Pregnancy
Condition: Hepatitis C
Intervention:
374 Recruiting Pegylated Interferon Alfa-2a Plus Low Dose Ribavirin for Treatment-Naïve Dialysis Patients With Chronic Hepatitis C
Condition: Chronic Hepatitis C
Interventions: Drug: Pegylated interferon alfa-2a plus low dose ribavirin;   Drug: Pegylated interferon alfa
375 Recruiting Quality of Life Therapy for Adults With Hepatitis C Virus and Cirrhosis Awaiting Liver Transplantation
Condition: Chronic HCV
Interventions: Behavioral: Quality of Life Therapy;   Behavioral: Supportive Therapy
376 Recruiting Trends in Risk Factors for Mother-to-Child Transmission of Hepatitis C Among a Southern European Population
Conditions: Hepatitis C Virus;   HIV Infections;   Pregnancy
Intervention:
377 Active, not recruiting Study Investigating Immunological Effects of Treatment for Chronic Hepatitis C Patients.
Conditions: Hepatitis C;   Liver;   Immunology;   Regulation
Intervention: Procedure: fine-needle aspiration biopsy
378 Active, not recruiting 4 Week Combination of BI 207127 NA With Peg-IFN and Ribavirin in Chronic HCV Patients
Condition: Hepatitis C, Chronic
Interventions: Drug: BI 207127 middle dose +SOC;   Drug: BI 207127 high dose+SOC;   Drug: Placebo + SOC;   Drug: BI 207127 low dose + SOC
379 Completed Study of CTS-1027 in Hepatitis C Patients
Condition: Chronic Hepatitis C Virus Infection
Intervention: Drug: CTS-1027
380 Completed Safety, Tolerability, PK and PD of SCH 900518 in Naive or Treatment-Experienced Subjects Infected With HCV Genotype 1 (Protocol No. P04695)(COMPLETED)
Condition: Hepatitis C, Chronic
Interventions: Drug: Drug: SCH 900518 Biologic: Peginterferon alfa-2b(PegIntron);   Drug: Drug: SCH 900518 Biologic: Peginterferon alfa-2b;   Drug: Drug: SCH 900518 Drug: Ritonavir (RTV) Biologic: Peginterferon alfa-2b (PegIntron);   Drug: Drug: SCH 900518 Drug: Ritonavir (RTV) Drug: Ritonavir (RTV) Biologic: Peginterferon alfa-2b (PegIntron)

Previous Page (341-360) Studies Shown (361-380) Next Page (381-400)
Save this search by bookmarking this page.
When you use your bookmark, the search will be performed again on the most recent collection of studies.
RSS Feeds for studies found by your search that were:
  First received in the last 14 days,  
  Last updated (includes received) in the last 30 days
  Hide Download Options
Download Content:
Zip readers with free trial versions:   WinZip   PKZIP




Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services